Business Segments Chongqing Zhifei Biological Products Co., Ltd.
Stocks
300122
CNE100000V20
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.36 CNY | 0.00% |
|
-0.64% | -34.50% |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
: Breakdown by Business Segment
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical Products | ||||||||||
Biochemical Product | 30.63B | 38.26B | 52.91B | 25.85B | 8.87B | |||||
Interest Expense | - | - | - | - | - | |||||
Income Tax Expense | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
EBT | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - | |||||
Net Income | - | - | - | - | - | |||||
Unallocated Others | 23.46M | 3.85M | 4.08M | 223M | 90.42M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Eastern China | 9.55B | 12.99B | 18.48B | 8.49B | 2.61B | |||||
South China | 4.36B | 7.53B | 9B | 4.37B | 1.91B | |||||
Southwest China | 4.12B | 5.04B | 7.23B | 4.36B | 1.29B | |||||
Central China | 4.77B | 5.59B | 6.48B | 3.08B | 1.21B | |||||
North China | 4.7B | 4.05B | 6.99B | 3.22B | 1.04B | |||||
Northwest China | 1.11B | 1.64B | 3.07B | 1.61B | 540M | |||||
Northeast China | 890M | 1.44B | 1.66B | 921M | 327M | |||||
Export | 1.16B | -463K | 9.23M | 17.7M | 34.7M |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition